Cat.No.L5000
A unique collection of 99008 compounds features numerous structurally diverse compounds and several alternate compositions.
Cited by 2 Publications
| Featured Inhibitors | Y-27632 Dihydrochloride SB431542 CHIR-99021 (Laduviglusib) RMC-7977 RMC-6236 (Daraxonrasib) MRTX1133 MG132 Z-VAD-FMK VT3989 IAG933 |
|---|
If you need to download the HTS Library for Drug Discovery Contents (.xlsx and .sdf), please contact us via info@selleckchem.com
• A unique collection of 99008 compounds features numerous structurally diverse compounds and several alternate compositions, which is used for high throughput screening (HTS) and high content screening (HCS)
• Molecules' weights range from 300 to 500, potential drug-likeness and druggability, easy to find active molecules and improve the efficiency of new drug screening
• Innovative compounds from 50 years’ research of the largest pharmaceutical company
| Formulation | 99008 compounds pre-dissolved in 10mM DMSO | ||
|---|---|---|---|
| Container | 384 Deep Well Plate Sealed With Aluminum Foil | ||
| Stability | 12 months | -20°C | in DMSO |
| 24 months | -80°C | in DMSO | |
| Shipping | Blue ice or dry ice | ||
Application of GPCR Compound Library in liver cancer (This article was published in Nature (IF=43) and took about 15 months):
Application of Kinase Inhibitor Library in colorectal cancer (This article was published in Nature Communications (IF=11) and took about 8 months):
Application of FDA-approved Drug Library in antivirus (This article was published in Cell Research (IF=17) and took about 13 months):
Application of FDA-approved Drug Library in metabolism (This article was published in Movement Disorders (IF=8) and took about 10 months):
Application of Epigenetics Compound Library in acute lymphoblastic leukemia (This article was published in Blood (IF=16) and took about 16 months):
Application of Inhibitor Library in tumor immunology (This article was published in Cancer Immunol Res (IF=8.6) and took about 12 months):